6.45
price up icon7.68%   0.46
after-market Dopo l'orario di chiusura: 6.45
loading

Monte Rosa Therapeutics Inc Azioni (GLUE) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
1.064
- - - -
Operating Expenses
3.29%
36.01
34.86 36.97 37.22 34.26
Benefits Costs and Expenses
32.95
- - - -
Costs And Expenses
32.95
- - - -
Operating Income/Loss
0.24%
-34.95
-34.86 -36.97 -37.22 -34.26
Nonoperating Income/Loss
92.70%
3.062
1.589 2.254 2.233 2.221
Income/Loss From Continuing Operations Before Tax
4.17%
-31.89
-33.27 -34.71 -34.99 -32.04
Income Tax Expense/Benefit
477.27%
0.083
-0.022 0.17 0.19 -
Income/Loss From Continuing Operations After Tax
3.86%
-31.97
-33.25 -34.88 -35.18 -32.04
Net Income/Loss
3.86%
-31.97
-33.25 -34.88 -35.18 -32.04
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
3,128%
60.16
1.8638 49.81 49.43 49.35
Diluted Average Shares
3,128%
60.16
1.8638 49.81 49.43 49.35
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$352.30
price down icon 5.49%
$41.04
price up icon 0.79%
$22.36
price up icon 3.33%
$5.41
price up icon 3.84%
biotechnology ONC
$226.89
price up icon 0.08%
$120.88
price down icon 0.23%
Capitalizzazione:     |  Volume (24 ore):